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In this article…  
 Understanding the risk factors for deep vein thrombosis 
 Diagnostic testing to inform an assessment   
 How to assess the leg for a suspected deep vein thrombosis 
 
 
Key points  
There are multiple risk factors for venous thromboembolic disorders, making this a 
complex condition to diagnose. 
The two-level Wells score is a systematic standardised approach to deep vein 
thrombosis assessment.  
Other risk factors and variables must be considered during a deep vein thrombosis 
assessment.  
The procedure of a leg assessment for a deep vein thrombosis assessment is within the 
skill set of nurses.  
Nurses must be aware of referral pathways and National Institute of Health and Care 




Nurses will increasingly be required to identify and assess for deep vein thrombosis 
in both primary and secondary care, so need the skills to assess the clinical risk of the 
patient. This article explains how to understand deep vein thrombosis in terms of its 
associated risk factors, use of the two-level Wells score for estimating a patient’s risk and 
how to carry out a leg assessment for a suspected deep vein thrombosis. 
 
 
A deep vein thrombosis (DVT) is a condition whereby a blood clot (a thrombus) is formed in 
a vein. This can dislodge and travel into the blood stream, and towards the lungs, where it 
can cause a pulmonary embolism (PE), which is a ‘blockage’ in the pulmonary circulation 
known to be life threatening (National Institute of Health and Care Excellence, 2020). DVT 
and PE are both in the category of venous thromboembolic (VTE) disorders. A DVT is most 
often found in the lower extremities and can be linked to increased morbidity by 
progressing to a pulmonary embolism or causing long term complications such as post 
thrombotic syndrome (Bhatt et al, 2020). Thromboses can potentially be found in every 
deep vein in the body; a DVT of the arm is another of the most common locations and is 
estimated to account for around 5% of all thromboses (Isma et al, 2010).  
 
Thomas (2014) identified that patients who are non-complex but have a suspected DVT are 
ideally placed to be diagnosed and managed in primary care. The development of treatment 
pathways as advocated by NICE (2020) aimed to prevent unnecessary hospital admissions, 
thereby reducing cost to the NHS. The NHS Long Term Plan focuses on improving the patient 
journey, which is key to increasing patient satisfaction and boosting proactive care by 
screening and diagnosing at risk patient groups earlier (NHS England, 2019).  
 
NHS England (2017), in Next Steps on the Five Year Forward View, identified DVT as a patient 
safety concern as part of its harm reduction initiative (NHS England, 2017). It reflected that 
nurses will increasingly be required to identify and assess for DVT in both primary and 
secondary care, so need the skills to assess the clinical risk of the patient.  VTE risk 
assessment is a National Quality Requirement as part of the NHS standard Contract 2020/21 
(NHS England, 2020). Furthermore, studies show that the severe inflammatory processes 
manifested by Covid-19 can increase the incidence of DVT (Sebuhyan, 2020). Thus, as 
diagnosing DVT is at the forefront of current care, the objectives of this article are to:  
 
 Understand DVT in terms of its associated risk factors; 
 Highlight the use of the two-level Wells score as a decision-making tool to estimate a 
patient’s risk of a DVT (Wells et al, 2003);  
 Demonstrate the process of a leg assessment for a suspected DVT. 
 
Causes of a DVT  
 
Virchow’s (1998) triad refers to three factors that can contribute to a venous thrombosis: 
 Venous trauma, whereby damage occurs to the vessel walls;  
 Venous stasis, characterised by poor blood flow; 
 Hypercoagulability, otherwise described as abnormal blood constituents (Welch and 
Bonner, 2010).  
 
The more risk factors people have the greater their risk of developing a thrombus. Patients 
who are pregnant, or have had recent hospitalisation or surgery, may become high risk 
because they are less mobile (which causes a reduction in blood flow) or have vascular wall 
injury as a result of an intervention. People with cancer with already increased coagulability 
may have had chemotherapy, be immunocompromised or have acquired infections, which 
can combine to make them high risk.  More recently, studies have found increased risk 
associated with a VTE in patients with severe Covid-19 admitted to critical care, despite 
prophylactic anticoagulation (Fontana et al, 2020; Hasan et al, 2020). There have been calls 
for further research into VTE, Covid-19, and therapeutic treatment of patients in this at-risk 
group on an individual basis instead of it being protocol driven (Hasan et al, 2020). Fig 1 
demonstrates the categories and some causes in Virchow’s triad, which can contribute to a 
thrombosis (Dunn and Kendall, 2020). 
 
The evidence-based screening tool advocated by NICE (2020) is the two-level Wells (2003) 
score (Fig 2). The tool is used to support decision making in practice and although the Wells 
score is systematic it cannot safely rule out a DVT in isolation. When the Wells score is 
calculated as 1 or less (which is considered low probability) and combined with a negative D-
dimer test it explicitly excludes a DVT (Iorio and Douketis, 2014). Patients score 1 point for 
any of the clinical features they present with on the screening tool. If it is considered that an 
alternative diagnosis to DVT is likely, it is always important to subtract 2 points from the 
total final score to produce the final outcome. In practice, decision-making tools should 
never override clinical autonomy, and patient safety is always our key priority. It must be 
noted that pregnancy is one exclusion of the Wells risk assessment, as the tool has not been 
validated for use in this situation and false positives, plus the potential for unnecessary 
anticoagulation of such a high-risk group, could lead to unnecessary harm (Righini, 2013). 
 
The Wells score as highlighted is comprehensive, but a patient’s history must not be 
overlooked, as many conditions that could predispose an individual to a thrombus are not 
included in its scoring system. For example, haematological conditions such as 
thrombophilia, pregnancy, autoimmune disorders, obesity and, more recently, Covid-19 can 
also increase the risk of a VTE. 
 
D-dimer testing  
Diagnostic testing is required to exclude VTE and inform the assessment and in addition to 
clotting, investigations including a D-dimer (see below), general inflammatory markers, a 
baseline blood count and hepatic and renal function are all considered best practice (NICE, 
2020). A D-dimer is a blood test that can detect levels of fibrin degradation (fibrin is a 
protein in the blood and a primary component of blood clotting). A value below 500 µg/L is 
conventionally used to safely rule out VTE with a low false negative rate. However, a D-
dimer range can vary according to the reagents used in laboratory testing and so may be 
different across hospitals; this must be taken into account when following a local pathway. 
A D-dimer has the advantage that it is quick and can be taken with other routine blood test 
for use in conjunction with a clinical history wherever there is clinical suspicion of VTE. 
Elevated levels are generally found in patients with conditions associated with thrombosis 
such as pregnancy and advanced cancer, and as such the D-dimer test should not be used 
independently of other investigations because it can produce false negatives (Weitz et al, 
2017).  
 
Developments in D-dimer testing mean that the age-adjusted D-dimer is now being used in 
combination with other clinical probability assessments to rule out suspicion of VTE, and the 
level of the result is adjusted accordingly to calculate the risk to the individual. An age-
adjusted D-dimer, with a cut off for patients aged 50 and above, for ruling out DVT has been 
deemed safe in some studies (Nybo and Hyas 2017; Rigini et al, 2014) and is recommended 
in the NICE (2020) guidance, although local policies and procedures must always be adhered 
to when treating and assessing DVT patients.  
 
Clinical assessment of the leg 
The leg needs to be examined fully to correctly use the Wells screening tool (Wells et al, 
2003) and examining a leg properly requires nurses to demonstrate a series of 
competencies and the steps are outlined in Box 1. 
 
Communication must be maintained throughout and the patient informed of the proposed 
plan of care. The clinical examination and consultation with the patient must be taken in the 
context of a full clinical history and the National Early Warning Score (NEWS 2) system 
(Royal College Physicians, 2017). 
 
A thorough clinical examination is important to highlight concerns, as in the next stage of 
the patient’s journey, it will be used in conjunction with a D-dimer test, or ultrasound in 
secondary or ambulatory care, to make a diagnosis following NICE guidance (NICE, 2020). 
Symptoms of a PE such as pleuritic chest pain, haemoptysis, or acute shortness of breath 
need assessed and  as this will inform the need for diagnostic imaging, such as a CT 
pulmonary angiogram. Fig 3 shows a patient with a DVT; notable features are an acutely 
swollen leg, dilatation of superficial veins, hot to touch and pain on palpation of calf. 




It is important to consider differential diagnosis when assessing for a DVT, not just for 
calculating the Wells Score, but to treat the patient’s symptoms, alleviate anxiety and, if the 
cause for the leg swelling is unclear, potentially investigate further. Other causes for a 
swollen leg may include chronic venous insufficiency, a baker’s cyst, superficial 
thrombophlebitis, cellulitis and musculoskeletal pain.  Schellong et al (2013) identify that 
other occurrences such as lower limb oedema, lymphoedema, diabetic foot lesions, and 
even tumours, can also lead to symptoms that resemble those of a DVT. This list of 
differential disgnosis is however is not exhaustive. 
 
Post procedure documentation  
 
Once a full assessment of the patient has been completed document the patient’s 
presenting complaint, history of presenting complaint, past medical history, current 
medication and the two-level Wells score at the time of your assessment. You should also 
document whether further investigation are required as per NICE guidance (2020). Date, 
time, printed name, signature and designation is required. The Nursing and Midwifery 
Council (2019) noted that safe and effective learning is a factor in proficient practice and use 
of documentation that has transferability across environments can support this. The Wells 
score is standardised and is transferrable for use in different areas of practice.  
 
Medical management  
 
NICE (2020) guidance states that once a patient has been assessed, if a DVT needs excluding, 
a proximal leg vein ultrasound scan is required. If a scan cannot be arranged within four 
hours the patient must receive an interim therapeutic dose of anticoagulation therapy, such 
as a low molecular weight heparin, until a DVT is excluded. Patients must be weighed for the 
correct dose and best practice is to explain the therapy they are receiving and supplement it 
with a patient information leaflet to alert them to the risk of bleeding or other 
complications they may experience while on therapy. Patients can be treated and 




The identification of a suspected DVT is the responsibility of nurses in all clinical settings, 
and the risk factors, implications and clinical assessment of suspected patients is in the skill 
set of all nurses. The identification of Covid-19 as a potential risk factor for a VTE may 
increase the prevalence of DVTs. There should therefore be greater awareness of the 
pathway of referral for further investigation to simplify the investigative process of this 
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Fig 1. The two level Wells screening tool 
HYPERCOAGULABLE STATE 
Malignancy 
Pregnancy and peri-partum period 
Oestrogen therapy 
Trauma or surgery of lower extremity, hip, abdomen or pelvis 




VASCULAR WALL INJURY 
Trauma or surgery 
Venepuncture 
Chemical irritation 
Heart valve disease or replacement 
Inflammatory bowel disease 
Atherosclerosis 




Left ventricular dysfunction 
Immobility or paralysis 
Venous insufficiency or varicose veins 







Fig 2. Two-level Wells risk assessment score (NICE, 2020)
 
Clinical feature          Point 
Active cancer (treatment ongoing, within 6 months or palliative)    1 
Paralysis, paresis or recent plaster immobilisation of the lower extremity  1 
Recently bedridden for 3 days or more, or major surgery within 12 weeks requiring 
general/regional anaesthesia        1 
Localised tenderness along the distribution of the deep venous system   1 
Entire leg swollen          1 
Calf swelling at least 3 cm larger than asymptomatic side     1 
Pitting oedema confined to the symptomatic leg collateral superficial veins (non-varicose) 1 
Collateral superficial veins (non-varicose)       1 
Previously documented DVT         1 
An alternative diagnosis is at least as likely as DVT      -2 
Clinical probability simplified score 
DVT likely         2 points or more 





[box starts] Box 1. How to examine a leg for assessment using the Wells screening tool 
1. Obtain informed consent from the patient and explain the procedure 
2. Maintain privacy and dignity at all times and consider a screened or cubicle area 
to assess your patient 
3. Wash your hands following local policy, and use PPE according to local policy 
4. Position the patient to allow full visibility of both legs and patient comfort 
5. Expose both patient limbs for assessment to compare and contrast limbs, and 
remove any tight clothing if necessary 
6. Observe both legs to identify any asymmetry or unilateral swelling, skin changes, 
wounds, oedema, erythema, superficial varicosities or existing varicosities 
7. Check for heat with your hand above the suspected area of DVT before palpation  
8. Palpate both legs, checking for pitting oedema, pain and breaks in the skin. Pain 
specific to the deep venous system can be a symptom of a DVT  (Wells et al, 
2003)  
9. Measure the difference in circumference of the calves; this is measured 10 cm 
below the tibial tuberosity. If there is more than 3 cm difference to the 
asymptomatic side a DVT is likely diagnosis (Wells et al, 1997) 
10. Palpate foot pulses. Check capillary refill time <2-3 seconds. Check the dorsalis 
pedis pulse (on the top of the foot)(Fig 4) and the posterior tibial pulse (located 
behind the medial malleolus - the ankle bone) (Fig 5)  
11. Assess if your patient can weight bear and mobilise effectively as part of your 
assessment and observation   
12. Assess range of movement in the patient’s joints by gently moving the leg to 
detect any arthritic swelling or acute pathology which may explain symptoms  
13. At the end of the assessment, make the patient comfortable and ensure their 
privacy and dignity 
14. Decontaminate your hands 
15. Documents your finding and report any concerns according to local policy  






Fig 4 Dorsal pedal pulse 
 
Fig 5 Posterior pedal pulse 
 
 
